Your browser doesn't support javascript.
loading
Effects of transcranial ultrasound stimulation pulsed at 40 Hz on Aß plaques and brain rhythms in 5×FAD mice.
Park, Mincheol; Hoang, Gia Minh; Nguyen, Thien; Lee, Eunkyung; Jung, Hyun Jin; Choe, Youngshik; Lee, Moon Hwan; Hwang, Jae Youn; Kim, Jae Gwan; Kim, Tae.
Afiliação
  • Park M; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.
  • Hoang GM; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.
  • Nguyen T; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.
  • Lee E; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.
  • Jung HJ; Korea Brain Research Institute, Daegu, 41062, Republic of Korea.
  • Choe Y; Korea Brain Research Institute, Daegu, 41062, Republic of Korea.
  • Lee MH; Department of Information and Communication Engineering, Daegu Gyeongbuk Institute of Science and Technology, Daegu, 42988, Republic of Korea.
  • Hwang JY; Department of Information and Communication Engineering, Daegu Gyeongbuk Institute of Science and Technology, Daegu, 42988, Republic of Korea.
  • Kim JG; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea. jaekim@gist.ac.kr.
  • Kim T; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea. tae-kim@gist.ac.kr.
Transl Neurodegener ; 10(1): 48, 2021 12 07.
Article em En | MEDLINE | ID: mdl-34872618
ABSTRACT

BACKGROUND:

Alzheimer's disease (AD) is the most common cause of dementia, and is characterized by amyloid-ß (Aß) plaques and tauopathy. Reducing Aß has been considered a major AD treatment strategy in pharmacological and non-pharmacological approaches. Impairment of gamma oscillations, which play an important role in perception and cognitive function, has been shown in mouse AD models and human patients. Recently, the therapeutic effect of gamma entrainment in AD mouse models has been reported. Given that ultrasound is an emerging neuromodulation modality, we investigated the effect of ultrasound stimulation pulsed at gamma frequency (40 Hz) in an AD mouse model.

METHODS:

We implanted electroencephalogram (EEG) electrodes and a piezo-ceramic disc ultrasound transducer on the skull surface of 6-month-old 5×FAD and wild-type control mice (n = 12 and 6, respectively). Six 5×FAD mice were treated with two-hour ultrasound stimulation at 40 Hz daily for two weeks, and the other six mice received sham treatment. Soluble and insoluble Aß levels in the brain were measured by enzyme-linked immunosorbent assay. Spontaneous EEG gamma power was computed by wavelet analysis, and the brain connectivity was examined with phase-locking value and cross-frequency phase-amplitude coupling.

RESULTS:

We found that the total Aß42 levels, especially insoluble Aß42, in the treatment group decreased in pre- and infra-limbic cortex (PIL) compared to that of the sham treatment group. A reduction in the number of Aß plaques was also observed in the hippocampus. There was no increase in microbleeding in the transcranial ultrasound stimulation (tUS) group. In addition, the length and number of microglial processes decreased in PIL and hippocampus. Encelphalographic spontaneous gamma power was increased, and cross-frequency coupling was normalized, implying functional improvement after tUS stimulation.

CONCLUSION:

These results suggest that the transcranial ultrasound-based gamma-band entrainment technique can be an effective therapy for AD by reducing the Aß load and improving brain connectivity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Doença de Alzheimer Limite: Animals / Humans Idioma: En Revista: Transl Neurodegener Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Doença de Alzheimer Limite: Animals / Humans Idioma: En Revista: Transl Neurodegener Ano de publicação: 2021 Tipo de documento: Article